
With rising demand from new treatments, this forum explored strategies for service development and capacity management.
This in-person event brought together healthcare professionals in Immuno-Oncology and Acute Oncology to examine key developments in service delivery and capacity management. Attendees learned from leading clinicians, connected with peers and were inspired to optimise, develop and expand their immunotherapy teams through focused, expert-led sessions.
Following the huge success of our previous collaborative forum with the IOCN in Coventry in October 2024, we were thrilled to partner with them again to deliver this meeting.
Supported by and in collaboration with:
Sponsored by:
Roche Products Ltd has provided financial support for
this meeting, but had no involvement in the agenda, other than the stated Roche
organised presentation
MSD has provided financial support for this meeting,
but had no involvement in the agenda, other than the stated MSD organised
presentation
5 hours Continuing Professional Development and networking
Attendees benefited from a programme packed with presentations from enthusiastic speakers who provided key advice to improve practice. They also took part in unique, dedicated discussion sessions to discover what other teams were doing and learn from one another.
Key IO updates: Impact of new immunotherapies on service delivery and capacity management
Crucial content: core concerns were tackled
- Service and capacity: strategies to improve and expand IO services
- Delivery approach: effective immunotherapy delivery and support
- Team development: aligning workforce and building strong MDTs
- Training: standardising training to manage treatment complexities
- Expansion and funding: growing services and accessing necessary resources
Why attendees joined the event
This dedicated training day armed attendees with the tools to deliver an effective and optimised service:
- Building networks: Attendees gained access to Immuno-Oncology professionals and thought leaders, building a community of peers for support, advice, and guidance
- Professional learning: They developed their understanding by examining and addressing key issues that underpin evolving IO services
- Service development: By taking one day out at this dedicated forum, participants identified innovative approaches to develop their services and increase capacity
With thanks to our sponsors
SBK would like to thank B. Braun, MSD and Roche for sponsoring this unique forum.
Roche Products Ltd has provided financial support for this meeting, but had no involvement in the agenda, other than the stated Roche organised presentation
MSD has provided financial support for this meeting, but had no involvement in the agenda, other than the stated MSD organised presentation
With thanks to our exhibitor
SBK would like to thank Amgen for exhibiting this unique forum.
Amgen has provided financial support for this meeting, but had no involvement in the agenda, other than the stated Amgen organised presentation
With thanks to our partner
This forum has been created in collaboration with and through support from IOCN
8:30 |
Registration and networking
|
9:00 |
Chair’s opening remarks and introductions
Dr Anna Olsson-Brown, Consultant in Medical Oncology and Clinical Director for Clinical Cancer Care, University Hospitals Sussex NHS Foundation Trust
|
National approach to IO capacity | |
9:10 |
Key developments: Managing increasing capacity and more complex immunotherapies
Dr Anna Olsson-Brown, Consultant in Medical Oncology and Clinical Director for Clinical Cancer Care, University Hospitals Sussex NHS Foundation Trust
|
9:35 |
Utilising subcutaneous delivery of immunotherapy to improve capacity in your service
Katie Hemer, Lead SACT Nurse, Clatterbridge Cancer Centre, Clatterbridge Cancer Centre NHS Foundation Trust
|
10:00 |
Questions and answers with your speakers
|
10:10 |
Lung Cancer Expert Forum (LCEF) Spotlight: Decentralising SACT - What’s Working and Why it Matters
Joseph Williams, Specialist Clinical Pharmacist at The Christie NHS Foundation Trust
|
10:20 |
Question and answers with Joseph Williams
|
10:30 |
Networking break
|
10:50 |
Implementing a comprehensive delivery and support approach to immunotherapies
Ali Hodge, Nurse Consultant Immunotherapy, University Hospitals Sussex NHS Foundation Trust
|
11:15 |
Interactive discussion: Improving capacity in your IO service
|
Workforce development | |
11:35 |
Establishing your Immuno-Oncology team: meeting workforce and capacity challenges
Trudy Guinan, Immuno-Oncology Nurse Consultant, Clatterbridge Cancer Centre NHS Foundation Trust
|
12:00 |
Questions and answers with your speakers
|
12:10 |
Interactive discussion: Developing and growing a strong IO team
|
12:30 |
Networking lunch
|
1:30 |
Standardising training to deal with increased complexity of immunotherapies
Clare Barlow, Consultant Medical Oncologist, Somerset NHS Foundation Trust
|
Service expansion | |
1:55 |
How to develop and expand your immuno-oncology service to meet capacity demands
Lucy Ford, Immunotherapy Advanced Nurse Practitioner, Somerset NHS Foundation Trust
|
2:20 |
Questions and answers with your speakers
|
2:30 |
Interactive discussion: Expanding your service to meet capacity challenges
|
2:50 |
Networking break
|
3:10 |
Case study: Setting up and establishing an Immuno-Oncology service
Louise Townley-Jones and Lesley Stewart, Immunotherapy Clinical Nurse Specialists and Joanna Beeney, Lead Chemotherapy Nurse, University Hospitals of Derby and Burton NHS Foundation Trust
|
3:35 |
Questions and answers with your speakers
|
3:45 |
Interactive discussion: Building your action plan for service development
|
4:05 |
Chair’s closing remarks and close of day
|
With thanks to the speakers

Anna Olsson Brown
Consultant in Medical Oncology and Clinical Director for Clinical Cancer Care
University Hospitals Sussex NHS Foundation Trust

Ali Hodge
Nurse Consultant Immunotherapy and Acute Oncology
University Hospitals Sussex NHS Foundation Trust

Trudy Guinan
Immuno-Oncology Nurse Consultant
Clatterbridge Cancer Centre NHS Foundation Trust

Clare Barlow
Consultant Medical Oncologist
Somerset NHS Foundation Trust

Lucy Ford
Immunotherapy Advanced Nurse Practitioner
Somerset NHS Foundation Trust
Katie Hemer
Lead SACT Nurse
Clatterbridge Cancer Centre, Clatterbridge Cancer Centre NHS Foundation Trust

Joseph Williams
Specialist Clinical Pharmacist
The Christie NHS Foundation Trust
Louise Townley-Jones
Immunotherapy Clinical Nurse Specialist
University Hospitals of Derby and Burton NHS Foundation Trust
Lesley Stewart
Immunotherapy Clinical Nurse Specialist
University Hospitals of Derby and Burton NHS Foundation Trust
Joanna Beeney
Lead Chemotherapy Nurse
University Hospitals of Derby and Burton NHS Foundation Trust
Who came?
This in-person forum was tailored for NHS professionals working within Immunotherapy MDTs, including the likes of:
- Lead Nurses, CNSs, Matrons, and Sisters in Cancer, Acute Oncology, Immunotherapy, Chemotherapy, CUP, Rapid Diagnostics, and Haematology
- Clinical Nurse Specialists and Consultants in Pain Management and Palliative Care
- Consultant Clinical Oncologists, Consultant Medical Oncologists, and Specialty Doctors
- Pharmacists, Medical Managers, and Service Managers
Attendee feedback
Past attendee feedback
With thanks to our conference supporter
The Immuno-Oncology Clinical Network was established in 2022 by Dr Anna Olsson-Brown and a team of trustees with a passion for improving the care of cancer patients receiving immunotherapy treatment. Dr Olsson-Brown recognised the need to build a multi-disciplinary and multi-specialty community to support healthcare professionals manage the complexities of Immuno-oncology treatments including the auto-immune side effects. The Immuno-Oncology Clinical Network applied for charitable status in Spring 2023.
With thanks to our sponsors
B. Braun is one of the world's leading medical technology companies. With over 66,000 employees, the family-owned company is a true partner, developing smart solutions and setting standards to drive advancements in health care.
At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases.
MSD has provided financial support for this meeting,
but had no involvement in the agenda, other than the stated MSD organised
presentation
At Roche UK, we focus our energy and investment in developing tests and treatments that change lives and give us more quality time with the people we love. And, together with others, we’re aiming to solve healthcare’s greatest challenges; helping to achieve better results by connecting early diagnosis to targeted treatment and ongoing support.
Date of Preparation: February 2025 / M-GB-00021496
Roche
Products Ltd has provided financial support for this meeting, but had no
involvement in the agenda, other than the stated Roche organised presentation
With thanks to our exhibitor
Amgen has provided financial support for this meeting, but had no involvement in the agenda, other than the stated Amgen organised presentation
Why sponsor an Oncology National Networking Forum?
Our role at SBK Healthcare is to bring industry together with healthcare professionals so that you can educate and inform your audience. These trail-blazing oncology forums offering dedicated presentation, Q&A, networking and discussion time, each sponsor will be fully immersed into the event and able to effectively engage with your NHS audience.
Interested in having your own event, managed by us?
SBK Healthcare also provides in-house forums. Working closely with you as the client we can research, produce, market and deliver the conference or online forum that best suits the audience and meets your goals.
Reach out today
If you would like more information on our sponsorship options an in-house forum or if you wish to discuss your needs and what solutions may be appropriate for your business, please contact:
Vanessa Pearce
Contact: 01732 897788
Please login to access documentation associated with the event. This is an exclusive benefit for all of the attendees and includes additional and updated documentation.